Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mindfulness program aims to ease childbirth fears in First-Time moms

NCT ID NCT07624253

Symptom relief Sponsor: Nigde Omer Halisdemir University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a 4-week online mindfulness-based psychoeducation program for first-time pregnant women who have moderate to severe fear of childbirth. The program includes relaxation exercises, emotional awareness, and coping strategies. Researchers will measure changes in fear levels, self-perception, and spiritual well-being compared to women receiving standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mindfulness-based psychoeducation program
What this could lead to
If it works, this could offer a simple, non-drug way to help pregnant women feel less afraid and more confident about childbirth.
What could go wrong
This is a small, early-stage trial with only 72 participants, so results may not apply to everyone. The intervention is online and group-based, which may not suit all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 72 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Willing to participate in the study, * Aged between 18-40 years, * Primigravida (first pregnancy), * Not having received any childbirth preparation class, * Scoring 38 or above on the Wijma Delivery Expectancy/Experience Questionnaire, * Between 20 and 34 weeks of gestation, * Having a healthy pregnancy, * Having a singleton pregnancy, * Carrying a live fetus, * Not in active labor, * Able to speak Turkish and without any language, comprehension, or communication problems to understand and answer the questions. Exclusion Criteria: * Those who do not agree to participate in the study, * Pregnant women under 18 years of age and over 41 years of age, * Diagnosed with high-risk pregnancy, * Illiterate, * Having a contagious disease, * Having a current or past psychiatric disorder requiring treatment, * Having mobility, hearing, or psychological disabilities, * With a gestational age below 20 weeks or above 32 weeks, * Those who have entered active labor. Withdrawal / Exclusion Criteria * Participants who withdraw consent and wish to leave the study during the study period, * Participants who are unable to adapt to the intervention process, * Participants experiencing communication or internet connectivity problems, * Participants who develop complications during the intervention (e.g., onset of labor, decreased fetal movements, etc.) requiring hospitalization will be excluded from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fear of childbirth are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fear of childbirth Pregnancy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Niğde Ömer Halisdemir Eğitim ve Araştırma Hastanesi

    Niğde, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.